Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;34(2):678-683.
doi: 10.1111/jvim.15718. Epub 2020 Feb 5.

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs

Amanda Kuhl  1 , Adesola Odunayo  1 , Josh Price  1 , Silke Hecht  1 , Kristen Marshall  1 , Joerg Steiner  2 , M Katherine Tolbert  2
Affiliations

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs

Amanda Kuhl et al. J Vet Intern Med. 2020 Mar.

Erratum in

Abstract

Background: Upper gastrointestinal (GI) ulceration and bleeding in critically ill dogs can cause severe anemia and increase morbidity. Acid suppressants using proton pump inhibitors or histamine-2 receptor blockers administered IV is commonly recommended.

Hypothesis/objectives: To evaluate the efficacy of IV administered esomeprazole, pantoprazole, and famotidine constant rate infusion (CRI) on increasing the intragastric pH of dogs. We hypothesized that esomeprazole and famotidine CRI would provide superior acid suppression compared to pantoprazole and reach pH goals for the treatment of GI bleeding.

Animals: Nine healthy research Beagles.

Methods: Randomized, 3-way crossover. Dogs received pantoprazole or esomeprazole at 1 mg/kg IV q12h and famotidine with a loading dose of 1 mg/kg followed by 8 mg/kg IV CRI daily for 3 consecutive days. The intragastric pH was recorded at baseline and for 72 hours of treatment. The mean pH and the mean percentage time (MPT) the intragastric pH was ≥3 or ≥4 were compared among and within treatment groups.

Results: Significant increases in mean pH (P < 0.0001), MPT ≥3 (P < 0.001), and MPT ≥4 (P = 0.0006) were noted over time with all 3 treatments. The time effect did not differ by treatment for mean pH, MPT ≥3, and MPT ≥4 (P = .29, .56, and .37, respectively); however, only esomeprazole and famotidine CRI achieved the goals established for the treatment of gastroduodenal ulceration in people.

Conclusions and clinical importance: Famotidine CRI and esomeprazole might be superior acid suppressants compared to standard doses of pantoprazole for the first 72 hours of treatment.

Keywords: bravo monitoring; canine; histamine-2 receptor antagonist; proton pump inhibitor.

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The mean percentage time (MPT) intragastric pH ≥3 for all dogs receiving 1 mg/kg q12h esomeprazole, pantoprazole, and 8 mg/kg/day famotidine constant rate infusion (CRI) on treatment days 1‐3. Horizontal and vertical lines represent the mean and standard deviations, respectively. Individual dog data are represented by green circles (pantoprazole), blue squares (esomeprazole), and red triangles (famotidine CRI). Significant increases in MPT intragastric pH ≥3 were noted over time (P = .001) with all 3 treatments. No significant treatment (P = .56) or treatment‐by‐time interaction (P = .56) were observed
Figure 2
Figure 2
The mean percentage time (MPT) intragastric pH ≥4 for all dogs receiving 1 mg/kg q12h esomeprazole, pantoprazole, and 8 mg/kg/day famotidine constant rate infusion (CRI) on treatment days 1‐3. Horizontal and vertical lines represent the mean and standard deviations, respectively. Individual dog data are represented by green circles (pantoprazole), blue squares (esomeprazole), and red triangles (famotidine CRI). Significant increases in MPT intragastric pH ≥4 were noted over time (P = .001) with all 3 treatments. No significant treatment (P = .96) or treatment‐by‐time interaction (P = .37) were observed
Figure 3
Figure 3
The mean pH for all dogs receiving 1 mg/kg q12h esomeprazole, pantoprazole, and 8 mg/kg/day famotidine constant rate infusion (CRI) on treatment days 1‐3. Horizontal and vertical lines represent the mean and standard deviations, respectively. Individual dog data are represented by green circles (pantoprazole), blue squares (esomeprazole), and red triangles (famotidine CRI). Significant increases in mean pH were noted over time with all 3 treatments (P < .001). No significant treatment (P = .77) or treatment‐by‐time interaction (P = .29) were observed
Figure 4
Figure 4
The mean percentage time (MPT) intragastric pH ≥5 for all dogs receiving 1 mg/kg q12h esomeprazole, pantoprazole, and 8 mg/kg/day famotidine constant rate infusion (CRI) on treatment days 1‐3. Horizontal and vertical lines represent the mean and standard deviations, respectively. Individual dog data are represented by green circles (pantoprazole), blue squares (esomeprazole), and red triangles (famotidine CRI)
Figure 5
Figure 5
The mean percentage time (MPT) intragastric pH ≥6 for all dogs receiving 1 mg/kg q12h esomeprazole, pantoprazole, and 8 mg/kg/day famotidine constant rate infusion (CRI) on treatment days 1‐3. Horizontal and vertical lines represent the mean and standard deviations, respectively. Individual dog data are represented by green circles (pantoprazole), blue squares (esomeprazole), and red triangles (famotidine CRI)
See this image and copyright information in PMC

References

    1. Waldrop JE, Rozanski EA, Freeman LM, et al. Packed red blood cell transfusions in dogs with gastrointestinal hemorrhage: 55 cases (1999–2001). J Am Anim Hosp Assoc. 2003;39:523‐527. - PubMed
    1. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology. 1990;99:345‐351. - PubMed
    1. Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro‐oesophageal reflux disease. Digestion. 1992;51(Suppl 1):59‐67. - PubMed
    1. Green FW Jr, Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74:38‐43. - PubMed
    1. Cheng HC, Sheu BS. Intravenous proton pump inhibitors for peptic ulcer bleeding: clinical benefits and limits. World J Gastrointest Endosc. 2011;3:49‐56. - PMC - PubMed

Publication types